Effect of Hemodialysis Membranes on Platelet Count

Completed

Conditions studied: Thrombocytopenia

In brief

The purpose of this study is to determine if there is a drop in platelet count after hemodialysis. Hemodialysis membranes are known to activate complement and cause a drop in platelets and sometimes in white blood cells. The investigators are going to study one of the membranes which is the Fresenius Optiflux® to check if it causes a drop in platelets.

Key facts

Study ID

NCT01356576

Run by

Northwell Health

People needed

99

Starts

2010-09-01

Expected to finish

2011-09-01

Last updated by the study team

2014-02-07

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients on Hemodialysis for >=6 months

You may not qualify if…

• Hematological Cancers
• Myelodysplastic syndromes
• Baseline thrombocytopenia
• Acute infections (patients on antibiotics)
• Patients with Immune thrombocytopenic purpura (ITP)/Thrombotic thrombocytopenic purpura (TTP)
• HIV
• Liver disease

Where it is running

• Island Rehabilitative Service — Staten Island, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.